Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of ASC30 injection for obesi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ASC30 injection (ASC30)

Snippet

Sponsor: Ascletis Pharma (China) Co., Limited | Conditions: Chronic Weight Management | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING